Navetco National Veterinary Joint Stock Company (UPCoM: VET)
19,000
Open19,000
High19,000
Low19,000
Vol500
Market Cap.304
Remain Bid2,800
Remain Ask12,500
52Wk High41,800
52Wk Low19,000
52Wk Avg Vol3,646
Foreign Buy-
Frgn Owned(%)-
Dividend40
Dividend Yield-
Beta0.61
EPS1,761
P/E10.87
F P/E8.05
BVPS20,423
P/B0.94
- Overview
- Trading
- Technical Analysis
- Financials
- Profile
- News & Events
- Industry Peers
- Documents
- Internal Trading
- Bonds
| Date | Close | Change | Volume |
|---|---|---|---|
| 10/16/2024 | 19,000 | -100 (-0.52%) | 500 |
| 10/15/2024 | 19,100 | -100 (-0.52%) | 3,500 |
| 10/14/2024 | 19,200 | 0 (0.00%) | 0 |
| 10/11/2024 | 19,200 | -300 (-1.54%) | 5,532 |
| 10/10/2024 | 19,100 | -500 (-2.55%) | 5,600 |
| 10/03/2024 | VET: Board Resolution |
| 09/19/2024 | VET: The incident involving the NAVET-LPVAC vaccine |
| 09/06/2024 | VET: Notice of record date for a ballot |
| 09/04/2024 | VET: Board Resolution |
| 08/29/2024 | VET: Resignation letter |
| 03/21/2024 | VET Dividend payment in cash with 0.40% (Tranche 2/2022) (Record date) |
| 03/21/2024 | VET Dividend payment in cash with 0.40% (Tranche 2/2022) |
| 09/29/2023 | VET Dividend payment in cash with 20.00% for 2022 (Record date) |
| 09/29/2023 | VET Dividend payment in cash with 20.00% for 2022 |
| 09/27/2022 | VET Dividend payment in cash with 26.62% for 2021 (Record date) |
| 08/16/2024 | Reviewed FS the first 6 month of 2024 |
| 07/19/2024 | FS Quarter 2 of 2024 |
| 07/11/2024 | Corporate Governance Report the first 6 month of 2024 |
| 06/18/2024 | Regulations 2024 |
| 06/14/2024 | Resolution of Annual Shareholders' Meeting 2024 |
Name: Navetco National Veterinary Joint Stock Company
Abbreviation:NAVETCO
Address: 29A Nguyen Dinh Chieu Street, Da Kao Ward District 1 Ho Chi Minh
Telephone: (028) 3822 5063
Fax: (028) 3822 5060
Email:info@navetco.com.vn
Website:https://www.navetco.com.vn
Exchange: UPCoM
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 12/13/2017
Chartered capital: 160,000,000,000
Listed shares: 16,000,000
Shares outstanding: 16,000,000
Status: Operating
Tax code: 0300600417
Establishment license:
Issued date:
Business license: 0300600417
Issued date: 03/07/2005
Main business scope:
- Manufacturing, trading veterinary medicine and aquaculture products.
- Researching on veterinary science and the prevention and control of veterinary diseases.
- National reserve of veterinary medicine, aquaculture products.
- 1955: National Institute of Microbiology and Livestock Diseases was established;
- 1975: Renamed as Veterinary and Castle Pathology Institute under Vietnam Administration of Agriculture;
- 1985: Renamed as Southern Veterinary Center;
- 1992: Renamed as National Veterinary Company No. 2;
- 2004: Transformed into National Veterinary One-member Limited Company;
- 14 November 2012: Ministry of Agriculture and Rural Development issued the Decision No.2899/QD-BNN-DMDN on approving the plan of equitizing and transforming National Veterinary One-member Limited Company into a joint stock company;
- 30 January 2013: Initial Public Offering (IPO) was launched at Ho Chi Minh Stock Exchange (HOSE);
- 05 November 2013: Put into operation under the model of a joint stock company with a charter captial of VND160 billion udner the business registration certificate No.0300600417 amended for the third time by Ho Chi Minh Department of Planning and Investment;
- 28 February 2014: Became a public company;
- 13 December 2017: Traded on UPCOM market;
- 05/16/2024 VET General Meeting of Shareholders for 2024
- 03/21/2024 VET Dividend payment in cash with 0.40% (Tranche 2/2022) (Record date)
- 03/21/2024 VET Dividend payment in cash with 0.40% (Tranche 2/2022)
- 12/14/2023 VET Extraordinary General Meeting of Shareholders for 2023
- 09/29/2023 VET Dividend payment in cash with 20.00% for 2022 (Record date)
| Items | Unit |
|---|---|
| Price | VND |
| Volume | Shares |
| Foreigner's, Yield | % |
| Mkt Cap | bVND |
| Financial indicators | mVND |
| EPS, BVPS, Dividend | VND |
| P/E, F P/E, P/B | Times |
| ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
